Monday, Sep 29, 2025 · SEC filings
What the smart money revealed on Sep 29
203 insider filings came in. We hid 29 planned (10b5-1) sellers and 106 people whose filings were routine, like grants and tax withholding.
Prospect Capital (PSEC) CEO John Barry bought $2.52M
925,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 6 checked quarters beat the typical stock 6 months later.
Prospect Capital (PSEC) COO M Eliasek bought $1M
370,000 shares on the open market. Not a grant or an option exercise. Their past buys: 0 of 5 checked quarters beat the typical stock 6 months later.
TON Strategy (TONX) Director Manuel Stotz bought $498K
70,000 shares on the open market. Not a grant or an option exercise.
Ategrity Specialty Insurance (ASIC) Director Stuart Zimmer bought $193K
9,920 shares on the open market. Not a grant or an option exercise.
United Therapeutics (UTHR) Chairperson & CEO Martine Rothblatt sold $3.44M
Not marked as a planned 10b5-1 sale. Sold 98% of the shares they held directly. Still holds 130 shares.
Hallador Energy (HNRG) Director David Hardie sold $2.19M
Not marked as a planned 10b5-1 sale. Sold 56% of the shares they held directly. Still holds 89,518 shares.
CareCloud (CCLD) Executive Chairman Mahmud Haq sold $252K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 15 more real buys
Show 18 more real sales
13F season
Holdings as of Jun 30, 2025 were due Aug 14
74 funds have filed. 68 filed for the quarter before.
Biggest real insider buys, Sep 23–29
Open-market buys by officers and directors, filed in the 7 days up to Sep 29.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.